Results 201 to 210 of about 86,843 (248)
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Subunit fusion unlocks rapid <i>in vitro</i> maturation for slowly activating heterodimeric [FeFe]-hydrogenases. [PDF]
Jaenecke J +10 more
europepmc +1 more source
Richesse en protéines de quelques Sorghos cultivés au CRA de Bambey : variations dans le même groupe botanique et ses relations avec la vitrosité du grain [PDF]
Bono, Marius, Vidal, Prosper
core
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Radiobiologie Cellulaire et Biochimique. Rapport Final 1964. EUR 2201. = Cellular and Biochemical Radiobiology. Final Report 1964. EUR 2201. [PDF]
core
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
Simple genetic mechanisms toward more intricate molecular complexes. [PDF]
Cisneros AF, Landry CR.
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Bridging the species divide: The limits of rat models in capturing human PVOD mechanisms. [PDF]
Perros F, Chaveroux C, Montani D.
europepmc +1 more source

